• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Optimizing antiplatelet / antithrombotic therapy.优化抗血小板/抗血栓治疗。
Ann Indian Acad Neurol. 2010 Jul;13(3):233. doi: 10.4103/0972-2327.70888.
2
Dual antithrombotic therapy increases severe bleeding events in patients with stroke and cardiovascular disease: a prospective, multicenter, observational study.双重抗栓治疗增加中风和心血管疾病患者的严重出血事件：一项前瞻性、多中心、观察性研究。
Stroke. 2008 Jun;39(6):1740-5. doi: 10.1161/STROKEAHA.107.504993. Epub 2008 Apr 3.
3
Impact of Preinjury Antithrombotic Therapy on 30-Day Mortality in Older Patients Hospitalized With Traumatic Brain Injury (TBI).伤前抗血栓治疗对创伤性脑损伤（TBI）住院老年患者30天死亡率的影响。
Front Neurol. 2021 May 13;12:650695. doi: 10.3389/fneur.2021.650695. eCollection 2021.
4
"Triple therapy" rather than "triple threat": a meta-analysis of the two antithrombotic regimens after stent implantation in patients receiving long-term oral anticoagulant treatment.三联抗栓治疗而非三联威胁：长期口服抗凝治疗患者支架植入术后两种抗栓方案的荟萃分析。
Chest. 2011 Feb;139(2):260-270. doi: 10.1378/chest.09-3083.
5
Prestroke and Poststroke Antithrombotic Therapy in Patients With Atrial Fibrillation: Results From a Nationwide Cohort.卒前和卒后抗栓治疗在伴房颤患者中的应用：一项全国性队列研究结果。
JAMA Netw Open. 2018 May 18;1(1):e180171. doi: 10.1001/jamanetworkopen.2018.0171.
6
Antithrombotic and antiplatelet therapies in relation to risk stratification in patients with non-ST elevation acute coronary syndrome: insights from the Sino-Global Registry of Acute Coronary Events.非ST段抬高型急性冠状动脉综合征患者抗栓和抗血小板治疗与风险分层的关系：来自中国全球急性冠状动脉事件注册研究的见解
Chin Med J (Engl). 2009 Mar 5;122(5):502-8.
7
Antiplatelet and antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa receptor antagonist.新型血小板糖蛋白IIb/IIIa受体拮抗剂DMP 728的抗血小板和抗血栓形成疗效
Circulation. 1994 Jan;89(1):3-12. doi: 10.1161/01.cir.89.1.3.
8
Evaluation of surgery risk factor associated to antithrombotic therapy in patients who underwent colorectal surgery.接受结直肠手术患者中与抗血栓治疗相关的手术风险因素评估。
Ann Ital Chir. 2016;87:56-60.
9
Antithrombotic therapy after percutaneous coronary intervention from the Japanese perspective.从日本视角看经皮冠状动脉介入治疗后的抗栓治疗
Cardiovasc Interv Ther. 2020 Jan;35(1):19-29. doi: 10.1007/s12928-019-00633-6. Epub 2019 Dec 16.
10
Previous Antithrombotic Therapy, Particularly Anticoagulant, Is Associated with Unfavorable Outcomes in Patients with Primary Spontaneous Intracerebral Hemorrhage Receiving Craniotomy: A Nationwide Population-Based Cohort Study.先前的抗血栓治疗，特别是抗凝治疗，与接受开颅手术的原发性自发性脑出血患者的不良结局相关：一项全国范围内基于人群的队列研究。
World Neurosurg. 2019 Aug;128:e59-e73. doi: 10.1016/j.wneu.2019.03.269. Epub 2019 Apr 4.

本文引用的文献

1
Optimization of antiplatelet/antithrombotic therapy for secondary stroke prevention.用于二级卒中预防的抗血小板/抗血栓治疗的优化。
Ann Indian Acad Neurol. 2010 Jan;13(1):6-13. doi: 10.4103/0972-2327.61270.
2
Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial.动脉源性脑缺血后阿司匹林联合双嘧达莫与单用阿司匹林的疗效比较（ESPRIT）：随机对照试验
Lancet. 2006 May 20;367(9523):1665-73. doi: 10.1016/S0140-6736(06)68734-5.
3
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.抗血小板治疗预防高危患者死亡、心肌梗死和中风的随机试验协作荟萃分析。
BMJ. 2002 Jan 12;324(7329):71-86. doi: 10.1136/bmj.324.7329.71.
4
European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke.欧洲中风预防研究。2. 双嘧达莫和阿司匹林在中风二级预防中的应用
J Neurol Sci. 1996 Nov;143(1-2):1-13. doi: 10.1016/s0022-510x(96)00308-5.
5
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.氯吡格雷与阿司匹林对缺血性事件高危患者的随机、双盲试验（CAPRIE）。CAPRIE指导委员会。
Lancet. 1996 Nov 16;348(9038):1329-39. doi: 10.1016/s0140-6736(96)09457-3.
6
Individual variation in platelet aggregability and serum thromboxane B2 concentrations after low-dose aspirin.小剂量阿司匹林后血小板聚集性和血清血栓素B2浓度的个体差异。
Stroke. 1988 Jun;19(6):700-3. doi: 10.1161/01.str.19.6.700.
7
A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke.对短暂性脑缺血发作或轻度缺血性卒中患者使用两种剂量阿司匹林（每日30毫克与283毫克）的比较。
N Engl J Med. 1991 Oct 31;325(18):1261-6. doi: 10.1056/NEJM199110313251801.
8
Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. The SALT Collaborative Group.
Lancet. 1991 Nov 30;338(8779):1345-9.
9
Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin.低剂量至高剂量阿司匹林对血小板聚集性及血栓素A2和前列环素代谢产物的影响。
Stroke. 1992 Oct;23(10):1400-3. doi: 10.1161/01.str.23.10.1400.

Optimizing antiplatelet / antithrombotic therapy.

作者信息

Srijithesh P R

机构信息

Department of Neurology, SS Block, Jawaharlal Institute of Postgraduate, Medical Education and Research, Dhanvanthri Nagar, Pondicherry - 6.

出版信息

Ann Indian Acad Neurol. 2010 Jul;13(3):233. doi: 10.4103/0972-2327.70888.

DOI:10.4103/0972-2327.70888
PMID:21085541
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2981768/
Abstract
摘要